NL-OMON26668招募中不适用
A multicenter, double blind placebo controlled randomized trial for Benign esophageal Anastomotic Strictures: Savary dilation vs savary dilation with TriAmcinolon.
Maag-, darm-, leverziekten UMC Utrecht0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients with dysphagia grade 2-4 (Atkinson Dysphagia score) after esophagectomy with gastric tube reconstruction and cervical anastomosis;
- •2. Signed informed consent.
排除标准
- •1. Previous dilation;
- •2. Dysphagia due to (suspicion of) malignant tumour recurrence;
研究者
相似试验
尚未招募
不适用
Pediatric Formulation of bosentan in pulmonary arterial hypertension.NL-OMON20918ACTELION Pharmaceuticals LtdGewerbestrasse 16CH-4123 AllschwilSwitzerland30
已完成
2 期
A multicentre, double blind, placebo controlled, dose - finding clinical study for three doses of Antiadipositum X 112 T (Cathine-hydrochloride) vs. placebo in 240 patients with a body mass index (BMI) between 27 kg/m2 and 40 kg/m2E66.00DRKS00000543RIEMSER Arzneimittel AG241
进行中（未招募）
不适用
A Multicenter, Double Blind, Placebo controlled, Randomized study of TroVax vs Placebo in the First Line treatment of Patients with Metastatic Colorectal Cancer receiving Standard of Care.-----------------------------------------------------------------------------------------------Estudio multicéntrico, doble ciego, controlado con placebo y aleatorizado de TroVax? frente a placebo en el tratamiento de primera línea de pacientes con cáncer colorrectal metastásico que reciben el tratamiento habitual. - FLAMENCOMetastatic Colorectal Adenocarcinoma.-----------------------------------------------Adenocarcinoma Colorectal Metastásico.MedDRA version: 9.1Level: LLTClassification code 10052362Term: Metastatic colorectal cancerEUCTR2007-005639-26-ESOxford BioMedica1,300
进行中（未招募）
不适用
A Multicenter, Double Blind, Placebo controlled, Randomized study of TroVax vs Placebo in the First Line treatment of Patients with Metastatic Colorectal Cancer receiving Chemo-based Therapy. - FLAMENCOMetastatic Colorectal AdenocarcinomaMedDRA version: 9.1Level: LLTClassification code 10052362Term: Metastatic colorectal cancerEUCTR2007-005639-26-DEOxford BioMedica (UK) Limited1,312
进行中（未招募）
1 期
A Multicenter, Double Blind, Placebo controlled, Randomized study of TroVax vs Placebo in the First Line treatment of Patients with Metastatic Colorectal Cancer receiving Chemo-based Therapy. - FLAMENCOMetastatic Colorectal AdenocarcinomaMedDRA version: 9.1 Level: LLT Classification code 10052362 Term: Metastatic colorectal cancerEUCTR2007-005639-26-GBOxford BioMedica1,312